Fig. 7: Schematic diagram of the mechanism by which LINC00858 affects colon cancer.

LINC00858 can recruit the transcription factor RAD21, which in turn binds to the PCNP promoter to promote PCNP transcription and expression, thereby activating the STAT3/5 signaling pathway, promoting the proliferation, migration, and invasion of colon cancer cells, inhibiting their apoptosis, and ultimately promoting colon cancer progression.